25.5 C
New York
Tuesday, June 15, 2021

US recommends “pause” for Johnson & Johnson COVID vaccine to review blood clotting cases

The Center for Disease Control indicated in an alert on Tuesday that the Johnson & Johnson vaccine could begin as early as Wednesday. The vigil came after a chaotic day when the Food and Drug Administration recommended a “pause” for the vaccine, preventing almost every state using single-dose shots.

CDC Advisory Committee on Immunization Practices Call On Wednesday for the emergency session, with a scheduled vote at “updated recommendations for use” before the group adjourned at 4:30 pm ET.

Dr. Anthony Fauci, President Biden’s chief medical adviser, told Nora O’Donnell, anchor of “CBS Evening News”, on Tuesday night that it appeared that the adverse effects occurred within six to 13 days, and that “if you have this one month.” So two years ago, I think you don’t really have to worry about anything. “

Fauci stressed that the likelihood of these adverse side effects is “less than 1 in a million”, but he asked to be alert to symptoms such as severe headaches, some difficulty in movement – such as in neurological type conditions. Or some chest discomfort and difficulty breathing.

As of Monday, more than 6.8 million doses of the Johnson & Johnson vaccine were administered across the US, with a small portion of the total 190 million COVID vaccine shots given nationwide – most of them from Pfizer and Modern.

The White House said on Tuesday that the pause “would not have a significant impact” on the nationwide vaccine plan. President Biden assured the Americans that he has ensured that there are enough vaccine supplements in the US for all American adults from Pfizer and Modern.

In a handful of cases, the FDA and CDC are investigated in women and include a blood clot called venous sinus thrombosis of the brain, which, according to their statement, was seen with low levels of blood platelets. Symptoms were seen six to 13 days after vaccination in women, aged between 18 and 48.

“Treatment of this specific type of blood clotting is different from the treatment that can usually be administered. Typically, an anticoagulant drug called heparin is used to treat blood clots. In this setting, Administration of heparin can be dangerous, and requires alternative treatment. Be given, “he said.

Agencies said that “adverse events” appear to be extremely rare, but it is important that health care providers can be made aware of the reactions and properly identify and manage cases that require unique treatment Needed.

Ed O’Keefe contributed to this report.

Latest news

Related news


Please enter your comment!
Please enter your name here